[Islet beta-cell function in failures following sulfonylurea therapy in diabetics, by determination of serum C-peptide].
D000328:Adult; D000368:Aged; D002096:C-Peptide / Q000097:blood*; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000188:drug therapy*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy*; D005260:Female; D005934:Glucagon / Q000494:pharmacology; D006801:Humans; D007515:Islets of Langerhans / Q000503:physiopathology*; D008297:Male; D008875:Middle Aged; D013453:Sulfonylurea Compounds / Q000627:therapeutic use*
D002096:C-Peptide; D013453:Sulfonylurea Compounds; D005934:Glucagon
Función beta insular en fallas secundarias a las sulfonilureas en diabéticos, mediante la determinación del peptido C del suero.